Senseonics Holdings, Inc. (SENS)
6.75
-0.10
(-1.46%)
USD |
NASDAQ |
Dec 15, 12:51
Senseonics Holdings EPS Diluted (Quarterly): -0.4344 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DexCom, Inc. | 0.7035 |
| Celldex Therapeutics, Inc. | -1.009 |
| Atossa Therapeutics, Inc. | -0.0673 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Kiora Pharmaceuticals, Inc. | 0.0062 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.53M |
| Revenue (Quarterly) | 8.095M |
| Total Expenses (Quarterly) | 27.62M |
| Enterprise Value | 209.38M |
| Gross Profit Margin (Quarterly) | 42.84% |
| Profit Margin (Quarterly) | -241.3% |
| Earnings Yield | -19.71% |
| Normalized Earnings Yield | -19.71 |